Cargando…
Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design
Among broadly neutralizing antibodies to HIV, 10E8 exhibits greater neutralizing breadth than most. Consequently, this antibody is the focus of prophylactic/therapeutic development. The 10E8 epitope has been identified as the conserved membrane proximal external region (MPER) of gp41 subunit of the...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338832/ https://www.ncbi.nlm.nih.gov/pubmed/28225819 http://dx.doi.org/10.1371/journal.ppat.1006212 |
_version_ | 1782512564198965248 |
---|---|
author | Irimia, Adriana Serra, Andreia M. Sarkar, Anita Jacak, Ronald Kalyuzhniy, Oleksandr Sok, Devin Saye-Francisco, Karen L. Schiffner, Torben Tingle, Ryan Kubitz, Michael Adachi, Yumiko Stanfield, Robyn L. Deller, Marc C. Burton, Dennis R. Schief, William R. Wilson, Ian A. |
author_facet | Irimia, Adriana Serra, Andreia M. Sarkar, Anita Jacak, Ronald Kalyuzhniy, Oleksandr Sok, Devin Saye-Francisco, Karen L. Schiffner, Torben Tingle, Ryan Kubitz, Michael Adachi, Yumiko Stanfield, Robyn L. Deller, Marc C. Burton, Dennis R. Schief, William R. Wilson, Ian A. |
author_sort | Irimia, Adriana |
collection | PubMed |
description | Among broadly neutralizing antibodies to HIV, 10E8 exhibits greater neutralizing breadth than most. Consequently, this antibody is the focus of prophylactic/therapeutic development. The 10E8 epitope has been identified as the conserved membrane proximal external region (MPER) of gp41 subunit of the envelope (Env) viral glycoprotein and is a major vaccine target. However, the MPER is proximal to the viral membrane and may be laterally inserted into the membrane in the Env prefusion form. Nevertheless, 10E8 has not been reported to have significant lipid-binding reactivity. Here we report x-ray structures of lipid complexes with 10E8 and a scaffolded MPER construct and mutagenesis studies that provide evidence that the 10E8 epitope is composed of both MPER and lipid. 10E8 engages lipids through a specific lipid head group interaction site and a basic and polar surface on the light chain. In the model that we constructed, the MPER would then be essentially perpendicular to the virion membrane during 10E8 neutralization of HIV-1. As the viral membrane likely also plays a role in selecting for the germline antibody as well as size and residue composition of MPER antibody complementarity determining regions, the identification of lipid interaction sites and the MPER orientation with regard to the viral membrane surface during 10E8 engagement can be of great utility for immunogen and therapeutic design. |
format | Online Article Text |
id | pubmed-5338832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53388322017-03-09 Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design Irimia, Adriana Serra, Andreia M. Sarkar, Anita Jacak, Ronald Kalyuzhniy, Oleksandr Sok, Devin Saye-Francisco, Karen L. Schiffner, Torben Tingle, Ryan Kubitz, Michael Adachi, Yumiko Stanfield, Robyn L. Deller, Marc C. Burton, Dennis R. Schief, William R. Wilson, Ian A. PLoS Pathog Research Article Among broadly neutralizing antibodies to HIV, 10E8 exhibits greater neutralizing breadth than most. Consequently, this antibody is the focus of prophylactic/therapeutic development. The 10E8 epitope has been identified as the conserved membrane proximal external region (MPER) of gp41 subunit of the envelope (Env) viral glycoprotein and is a major vaccine target. However, the MPER is proximal to the viral membrane and may be laterally inserted into the membrane in the Env prefusion form. Nevertheless, 10E8 has not been reported to have significant lipid-binding reactivity. Here we report x-ray structures of lipid complexes with 10E8 and a scaffolded MPER construct and mutagenesis studies that provide evidence that the 10E8 epitope is composed of both MPER and lipid. 10E8 engages lipids through a specific lipid head group interaction site and a basic and polar surface on the light chain. In the model that we constructed, the MPER would then be essentially perpendicular to the virion membrane during 10E8 neutralization of HIV-1. As the viral membrane likely also plays a role in selecting for the germline antibody as well as size and residue composition of MPER antibody complementarity determining regions, the identification of lipid interaction sites and the MPER orientation with regard to the viral membrane surface during 10E8 engagement can be of great utility for immunogen and therapeutic design. Public Library of Science 2017-02-22 /pmc/articles/PMC5338832/ /pubmed/28225819 http://dx.doi.org/10.1371/journal.ppat.1006212 Text en © 2017 Irimia et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Irimia, Adriana Serra, Andreia M. Sarkar, Anita Jacak, Ronald Kalyuzhniy, Oleksandr Sok, Devin Saye-Francisco, Karen L. Schiffner, Torben Tingle, Ryan Kubitz, Michael Adachi, Yumiko Stanfield, Robyn L. Deller, Marc C. Burton, Dennis R. Schief, William R. Wilson, Ian A. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design |
title | Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design |
title_full | Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design |
title_fullStr | Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design |
title_full_unstemmed | Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design |
title_short | Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design |
title_sort | lipid interactions and angle of approach to the hiv-1 viral membrane of broadly neutralizing antibody 10e8: insights for vaccine and therapeutic design |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338832/ https://www.ncbi.nlm.nih.gov/pubmed/28225819 http://dx.doi.org/10.1371/journal.ppat.1006212 |
work_keys_str_mv | AT irimiaadriana lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT serraandreiam lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT sarkaranita lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT jacakronald lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT kalyuzhniyoleksandr lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT sokdevin lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT sayefranciscokarenl lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT schiffnertorben lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT tingleryan lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT kubitzmichael lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT adachiyumiko lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT stanfieldrobynl lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT dellermarcc lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT burtondennisr lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT schiefwilliamr lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign AT wilsoniana lipidinteractionsandangleofapproachtothehiv1viralmembraneofbroadlyneutralizingantibody10e8insightsforvaccineandtherapeuticdesign |